Results 31 to 40 of about 193,444 (218)

Medical Management of Angina Pectoris

open access: yes, 2021
Ischemic heart disease is nowadays the leading cause of death in the world and is most commonly presented as "Angina pectoris", characterised by chest pain and discomfort. Many strategies exist in the treatment of angina which include medical therapy and
Padganeh, Negin
core  

TRIMETAZIDINE INFLUENCE ON FILTRATION AND TUBULOINTERSTITIAL FUNCTION OF KIDNEYS IN ISCHEMIC HEART DISEASE PATIENTS WITH CHRONIC HEART FAILURE AND RENAL DYSFUNCTION

open access: yesРоссийский кардиологический журнал, 2018
Aim.  Evaluation of trimetazidine influence on the parameters of filtration and tubulo-interstinal function of kidneys in angina patients of II-III functional class (FC) and stable chronic heart failure (CHF) of II-III FC with chronic kidney disease (CKD)
N. A. Koziolova   +2 more
doaj   +1 more source

The Relationships between Physical and Emotional Symptoms and Health-Related Quality of Life of Patients after Percutaneous Coronary Intervention

open access: yesNurse Media: Journal of Nursing, 2023
Background: Percutaneous coronary intervention (PCI) for myocardial infarction patients has been shown to provide outstanding results, yet research has shown that patient quality of life varies.
Emil Huriani, Fitri Mailani
doaj   +1 more source

Pharmacological management of angina pectoris

open access: yes, 2021
Ischemic heart disease remains the leading cause of death in adults in the United States despite a decrease in the mortality rate of coronary heart disease in the last four years.
Emma-Okah, Rakel
core  

Ludwig's angina: a multidisciplinary concern. [PDF]

open access: yes, 2019
Although relatively uncommon, Ludwig’s angina is a potentially life-threatening infection of the floor of the mouth and neck. There is a danger of airway obstruction by swelling in the area and displacement of the tongue, and patients are at risk of ...
Parker, Emma, Mortimore, Gerri
core   +1 more source

Selection of medication in hospitalised elderly patients with Angina Pectoris [PDF]

open access: yes, 2004
Objective: To evaluate medication changes in hospitalised elderly patients diagnosed with angina pectoris and to compare the selection of medication with evidence-based treatment guidelines. Design: Review of medical notes and patient interview. Setting:
Gauci, Marise   +2 more
core  

Heart rate and use of beta-blockers in stable outpatients with coronary artery disease [PDF]

open access: yes, 2012
<p><b>Background:</b> Heart rate (HR) is an emerging risk factor in coronary artery disease (CAD). However, there is little contemporary data regarding HR and the use of HR-lowering medications, particularly beta-blockers, among ...
Abergel, Helene   +64 more
core   +1 more source

Effectiveness of legislative actions against tobacco smoking regarding the reduction of in-hospital morbidity of angina pectoris and myocardial infarction in Russia as a whole and 10 Russian constituent entities

open access: yesКардиоваскулярная терапия и профилактика, 2021
Russian anti-tobacco policy is aimed at reducing long-term morbidity and mortality from smoking-related diseases.Aim. To assess the associations of tobacco control (TC) legislative measures with hospitalization rate for myocardial infarction (MI) and ...
M. G. Gambaryan   +3 more
doaj   +1 more source

Clinical and cost-effectiveness analysis of an open label, single-centre, randomised trial of spinal cord stimulation (SCS) versus percutaneous myocardial laser revascularisation (PMR) in patients with refractory angina pectoris: The SPiRiT trial

open access: yes, 2008
Background: Patients with refractory angina have significant morbidity. This study aimed to compare two of the treatment options, Spinal Cord Stimulation (SCS) and Percutaneous Myocardial Laser Revascularisation (PMR) in terms of clinical outcomes and ...
Goldsmith KA   +40 more
core   +1 more source

An Unprecedented Association; Coronary Artery Disease and Sagliker Syndrome

open access: yesInternational Journal of the Cardiovascular Academy
Sagliker syndrome (SS) develops in chronic kidney disease patients because of insufficiently treated secondary hyperparathyroidism (SHPT) at an early stage.
İrem Yılmaz   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy